A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.

details{'conditions': ['Asthma'], 'countries': ['Germany', 'Sweden', 'United Kingdom'], 'interventions': [{'name': 'PF-610,355', 'type': 'DRUG', 'description': None}, {'name': 'Salmeterol', 'type': 'DRUG', 'description': None}], 'sponsors': [{'name': 'Pfizer', 'role': 'lead', 'agency_class': 'INDUSTRY'}], 'facilities': [{'zip': '14050', 'city': 'Berlin', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '22927', 'city': 'Großhansdorf', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '65187', 'city': 'Wiesbaden', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '413 45', 'city': 'Gothenburg', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Sweden'}, {'zip': '221 85', 'city': 'Lund', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Sweden'}, {'zip': 'M23 9QZ', 'city': 'Manchester', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'United Kingdom'}], 'outcomes': [], 'brief_summary': 'A study to determine the ability of different doses of PF-610,355 to open the airways in asthmatic patients by comparison with placebo and a marketed drug that also opens the airways in asthmatic patients.', 'study_type': 'INTERVENTIONAL', 'source_organization': 'Pfizer', 'results_first_posted_date': None, 'has_results_basis': 'results_first_posted_date'}→{'conditions': ['Asthma'], 'countries': ['Germany', 'Sweden', 'United Kingdom'], 'interventions': [{'name': 'PF-610,355', 'type': 'DRUG', 'description': None, 'other_names': [], 'design_groups': []}, {'name': 'Salmeterol', 'type': 'DRUG', 'description': None, 'other_names': [], 'design_groups': []}], 'composition_semantics': 'study_intervention_labels_not_product_formula', 'sponsors': [{'name': 'Pfizer', 'role': 'lead', 'agency_class': 'INDUSTRY'}], 'facilities': [{'zip': '14050', 'city': 'Berlin', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '22927', 'city': 'Großhansdorf', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '65187', 'city': 'Wiesbaden', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Germany'}, {'zip': '413 45', 'city': 'Gothenburg', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Sweden'}, {'zip': '221 85', 'city': 'Lund', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'Sweden'}, {'zip': 'M23 9QZ', 'city': 'Manchester', 'name': 'Pfizer Investigational Site', 'state': None, 'country': 'United Kingdom'}], 'outcomes': [], 'brief_summary': 'A study to determine the ability of different doses of PF-610,355 to open the airways in asthmatic patients by comparison with placebo and a marketed drug that also opens the airways in asthmatic patients.', 'study_type': 'INTERVENTIONAL', 'source_organization': 'Pfizer', 'results_first_posted_date': None, 'has_results_basis': 'results_first_posted_date', 'start_date_type': None, 'start_month_year': '2007-05', 'start_date_precision': 'month', 'completion_date_type': None, 'completion_month_year': None, 'completion_date_precision': None, 'primary_completion_date': None, 'primary_completion_month_year': None, 'primary_completion_date_precision': None, 'primary_completion_date_type': None, 'intervention_component_groups': [['unmapped:355', 'unmapped:pf-610'], ['salmeterol']], 'intervention_normalization': [{'name': 'PF-610,355', 'selected_label': 'PF-610,355', 'selection_basis': 'primary_label', 'role': 'study_intervention', 'components': ['unmapped:355', 'unmapped:pf-610'], 'unverified_label_components': ['unmapped:355', 'unmapped:pf-610'], 'items': [{'original': 'PF-610', 'component': 'unmapped:pf-610', 'status': 'unresolved', 'method': 'no_verified_mapping'}, {'original': '355', 'component': 'unmapped:355', 'status': 'unresolved', 'method': 'no_verified_mapping'}], 'excluded_accessory_parts': [], 'verified_other_name_component_sets': []}, {'name': 'Salmeterol', 'selected_label': 'Salmeterol', 'selection_basis': 'primary_label', 'role': 'study_intervention', 'components': ['salmeterol'], 'unverified_label_components': [], 'items': [{'original': 'Salmeterol', 'component': 'salmeterol', 'status': 'resolved', 'method': 'versioned_lexicon'}], 'excluded_accessory_parts': [], 'verified_other_name_component_sets': []}]}